BRAF and neoplasm: While the classical subtype is associated with a good prognosis, the tall cell variant of PTC is more aggressive and has a worse prognosis; some researchers attribute the poor prognosis to mutations in the B-Raf proto-oncogene rather than its tall columnar cells and larger tumor size [9].